Thursday, June 30, 2016| Latest E-book
You are here:
Cipla
#

Cipla

Articles

Prices of cancer, diabetes, blood pressure drugs slashed by 25%

Jun 06, 2016

Prices of cancer, diabetes, blood pressure drugs slashed by 25%

Prices of 56 important drugs used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 percent. #NewsTracker #Cipla #Lupin #Healthcare #Biocon #Novartis #Intas Pharmaceuticals #National Pharmaceutical Pricing Authority #Alkem Laboratories #Alembic #Hetero Healthcare #reduced drugs prices #reduced medicine prices
Prices of 56 drugs to come down; NPPA fixes ceiling rates

Jun 06, 2016

Prices of 56 drugs to come down; NPPA fixes ceiling rates

Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism. #Cipla #Lupin #Biocon #Medicines #cancer treatment #Novartis #Drug prices #NPPA #DPCO #Alkem Laboratories #Abbott Healthcare #Alembic
FIPB clears 13 FDI proposals worth Rs 6,500 crore

Jan 22, 2016

FIPB clears 13 FDI proposals worth Rs 6,500 crore

Telecom tower firm Viom Networks' Rs 5,900 crore FDI proposal was among the 13 projects, totalling Rs 6,500 crore, that the foreign investment promotion board (FIPB) cleared today. #Cipla #FIPB #investments #Shaktikanta Das #Viom Networks #American Tower Corporation
Cipla ties up with US-based BioQ Pharma for supplying post-operative pain treatment drug

Jan 06, 2016

Cipla ties up with US-based BioQ Pharma for supplying post-operative pain treatment drug

BioQ Pharma and Cipla have inked a strategic distribution, supply and development agreement for the registration and commercialisation of BioQ Pharma's Ropivacaine infusion pharmaceutical in India #Cipla #BioQ Pharma #Ropivacaine infusion system
Cipla to transfer consumer healthcare business to subsidiary

Dec 10, 2015

Cipla to transfer consumer healthcare business to subsidiary

The company's board has approved the transfer of the consumer healthcare business to Cipla Health Ltd on a going concern basis by way of a slump sale for a lumpsum consideration of Rs 16 crore, Cipla said in a regulatory filing. #Business #Cipla #CompanyWatch #Healthcare #CAGR #Cipla Health
Cipla to sell entire stake in Biomab Holding for $25,775,000

Oct 29, 2015

Cipla to sell entire stake in Biomab Holding for $25,775,000

Biomab Holding is focused on developing Biosimilars for the Chinese market, it added. #Business #Health #Cipla #CompanyWatch #Biomab Holding #Biomab Brilliant #Cipla BioTec
Cipla, Serum Inst ink pact to supply vaccines in South Africa

Oct 08, 2015

Cipla, Serum Inst ink pact to supply vaccines in South Africa

Cipla Medpro, CEO, Paul Miller said the agreement will help the company become a significant player in the South African market. #Business #Medicine #Health #Cipla #CompanyWatch #Serum Institute of India
Cipla to acquire US-based InvaGen and Exelan for $550 mn

Sep 04, 2015

Cipla to acquire US-based InvaGen and Exelan for $550 mn

The acquisition of Exelan Pharmaceuticals provides Cipla access to government and institutional market in the US, Cipla said. #Business #Cipla #CompanyWatch #InvaGen Pharmaceuticals #Exelan Pharmaceuticals